• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH HI-TEC TOSOH HLC-723G8 ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH HI-TEC TOSOH HLC-723G8 ANALYZER Back to Search Results
Model Number G8
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Information (3190)
Event Date 01/27/2017
Event Type  malfunction  
Manufacturer Narrative
Evaluation of the customer's sample in tosoh's qa lab confirmed the customer's results.The g8 variant analysis mode operator's manual under chapter 1, introduction and applications, states that the level of la1c changes rapidly in response to changes in blood glucose concentration.However, the level of the sa1c does not fluctuate significantly in response to physiological factors.Consequently, the sa1c measurement provides a better indication of the average glucose level over the previous two to three months (the average red blood cell life span).A review of the information provided by the customer showed that the column count was at 3001 injections, which exceeded the 2500 injection count recommended by tosoh bioscience, inc.Root cause for the reported event could not be determined.(b)(4).
 
Event Description
On (b)(6) 2017 the customer reported results for sa1c of 5.2%, la1c of 5.1 % (above reportable range), and glucose of 244 mg/dl.The customer reported that the normal sa1c result of 5.2% did not match the patient's clinical history, which was typically higher.The customer was advised to send the specimen for testing with an alternative method; the specimen was sent out to be tested on roche's integra immunoturbometric methodology.On (b)(6) 2017 the customer reported that the test that was sent out to be tested on roche's integra immunoturbometric methodology had a sa1c result of 8.4%.The customer provided the chromatograms and upon review it was determined that further testing by tosoh's quality assurance (qa) lab would be required.The patient was currently on the following medication: betamethasone - dipropionate, ombivent respimat, metforman hcg extended release, pro-air hfa 108, simbacort, lidocaine mouth rinse.The customer confirmed that the sa1c of 5.2% result was reported out of the lab and questioned by the physician, because it was inconsistent with the patient's profile.On (b)(6) 2017 the customer called back to discuss tosoh's qa lab findings, which confirmed that the specimen ran in qc correlated with their result.The customer did question why there was a difference with the integra immunoturbometric methodology.The customer stated that the patient has not been in the clinic again for another ha1c test.
 
Manufacturer Narrative
Device evaluation by manufacturer: a 13-month complaint history review and service history review for similar complaints was performed for serial number (b)(4) from 27-dec-2015 through 27-jan-2017.There were no other similar complaints identified during the searched period.Report source: under the above section "user facility" was incorrectly selected.The only report source is "health professional".
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TOSOH HLC-723G8 ANALYZER
Type of Device
G8
Manufacturer (Section D)
TOSOH HI-TEC
1-37 fukugawa minami-machi
shunan-shi 746-0042, ja,
JA 
Manufacturer (Section G)
TOSOH BIOSCIENCE, INC. (IMPORTER)
6000 shoreline court
suite 101
south san francisco CA 94080
Manufacturer Contact
doria esquivel
6000 shoreline court
suite 101
south san francisco, CA 94080
6506368123
MDR Report Key6792860
MDR Text Key84344188
Report Number8031673-2017-00006
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K071132
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 12/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/14/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG8
Device Catalogue Number021560
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA12/27/2017
Distributor Facility Aware Date01/27/2017
Device Age9 YR
Event Location Outpatient Diagnostic Facility
Date Report to Manufacturer12/27/2017
Date Manufacturer Received01/27/2017
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/01/2008
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-